Inventor
GLENN JOSEPH
US28 patents
⚠️ This page may combine multiple inventors who share the name “GLENN JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
19 patentsUS9334274B2May 10, 2016
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
INCYTE CORP57 citations97
US10640506B2May 5, 2020
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
INCYTE CORP19 citations94
US10092570B2Oct 9, 2018
Heterocyclylamines as PI3K inhibitors
INCYTE CORP17 citations94
US9730939B2Aug 15, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations94
US9193733B2Nov 24, 2015
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
INCYTE CORP33 citations94
US10646492B2May 12, 2020
Heterocyclylamines as PI3K inhibitors
INCYTE CORP9 citations93
US10053465B2Aug 21, 2018
Pyrrolopyrimidine derivatives as TAM inhibitors
INCYTE CORP16 citations92
US11433071B2Sep 6, 2022
Heterocyclylamines as PI3K inhibitors
INCYTE CORP3 citations84
US11136326B2Oct 5, 2021
Pyrrolopyrimidine derivatives as TAM inhibitors
INCYTE CORP6 citations84
US9908895B2Mar 6, 2018
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP8 citations84
US7307086B2Dec 11, 2007
3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
INCYTE CORP21 citations84
US7678798B2Mar 16, 2010
Piperazinylpiperidine derivatives as chemokine receptor antagonists
INCYTE CORP5 citations74
US11851442B2Dec 26, 2023
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP1 citations73
US11161855B2Nov 2, 2021
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP3 citations73
US10519163B2Dec 31, 2019
Pyrrolopyrimidine derivatives as TAM inhibitors
INCYTE CORP4 citations73
US12201636B2Jan 21, 2025
Heterocyclylamines as PI3K inhibitors
INCYTE CORP0 citations63
US7618970B2Nov 17, 2009
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
INCYTE CORP5 citations63
US12415809B2Sep 16, 2025
Pyrrolotriazine compounds as tam inhibitors
INCYTE CORP0 citations62
US9067921B2Jun 30, 2015
Piperazinylpiperidine derivatives as chemokine receptor antagonists
INCYTE CORP0 citations52
XUE CHU-BIAO
4 patentsUS8268826B2Sep 18, 2012
Piperazinylpiperidine derivatives as chemokine receptor antagonists
XUE CHU-BIAO3 citations61
US8680104B2Mar 25, 2014
Piperazinylpiperidine derivatives as chemokine receptor antagonists
XUE CHU-BIAO0 citations51
US8563582B2Oct 22, 2013
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
XUE CHU-BIAO0 citations51
US8470827B2Jun 25, 2013
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
XUE CHU-BIAO0 citations51
RODGERS JAMES D
3 patentsUS9034884B2May 19, 2015
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
RODGERS JAMES D91 citations98
US8933085B2Jan 13, 2015
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
RODGERS JAMES D96 citations98
US8716303B2May 6, 2014
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
RODGERS JAMES D109 citations97